Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer.

Front Oncol · 2024 · PMC11410594 · PMID 39301544

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the overall survival (OS) did not reach statistical significance, partly due to a decrease in sample size after protocol amendment and a 26% cross-over rate in the docetaxel group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.